Save New Eucrisa as an Eczema Option After Topical Steroids

February 2017

The new Eucrisa (you-KRIS-ah, crisaborole) ointment will raise questions about how to manage eczema.

Eucrisa is the first new drug approved for eczema in over a decade. It inhibits phosphodiesterase 4...an enzyme that promotes inflammation.

Think of Eucrisa as a possible second-line med option for mild to moderate eczema...after topical corticosteroids.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote